Noradrenaline is necessary for the hedonic properties of addictive drugs

Vascular Pharmacology

Volumn 45, Issue 4, 2006, Pages 243-250

  Jasmin, Luc ^a   Narasaiah, Mena ^a   Tien, Duc ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cocaine; Dopamine beta hydroxylase; Mice; Morphine; Reward; Substance P

Indexed keywords

AMFEBUTAMONE; CARBIDOPA; COCAINE; DOPAMINE BETA MONOOXYGENASE; MORPHINE; NEUROKININ 1 RECEPTOR ANTAGONIST; NORADRENALIN; SUBSTANCE P; THREO 3,4 DIHYDROXYPHENYLSERINE;

ADDICTION; ADRENERGIC TRANSMISSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; APPETITE; ARTICLE; AVERSIVE BEHAVIOR; CENTRAL NERVOUS SYSTEM; COMORBIDITY; CONDITIONING; CONTROLLED STUDY; DEPRESSION; DRUG DEPENDENCE; EMOTION; FEMALE; FOOD PREFERENCE; MOUSE; NONHUMAN; NORADRENERGIC SYSTEM; PLACE PREFERENCE; PRIORITY JOURNAL; REWARD; TRANSGENIC MOUSE;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; APPETITIVE BEHAVIOR; BIPHENYL COMPOUNDS; BUPROPION; CARBIDOPA; COCAINE; DOPAMINE BETA-HYDROXYLASE; DOPAMINE UPTAKE INHIBITORS; DROXIDOPA; FEMALE; GENOTYPE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; MORPHINE; NALTREXONE; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, DOPAMINE D1; RECEPTORS, NEUROKININ-1; RECEPTORS, OPIOID; REWARD; SUBSTANCE-RELATED DISORDERS;

EID: 33750978676     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2005.08.030     Document Type: Article

References (91)

1. Amaral D.G., and Foss J.A. Locus coeruleus lesions and learning. Science 188 4186 (1975) 377-378
2. Antelman S.M., and Caggiula A.R. Norepinephrine-dopamine interactions and behavior. Science 195 4279 (1977) 646-653
3. Auclair A., Cotecchia S., Glowinski J., and Tassin J.P. D-amphetamine fails to increase extracellular dopamine levels in mice lacking alpha 1b-adrenergic receptors: relationship between functional and nonfunctional dopamine release. J. Neurosci. 22 21 (2002) 9150-9154
4. Ballard T.M., Sanger S., and Higgins G.A. Inhibition of shock-induced foot tapping behaviour in the gerbil by a tachykinin NK1 receptor antagonist. Eur. J. Pharmacol. 412 3 (2001) 255-264
5. Bardo M.T., and Bevins R.A. Conditioned place preference: what does it add to our preclinical understanding of drug reward?. Psychopharmacology (Berl) 153 1 (2000) 31-43
6. Braida D., Pozzi M., Cavallini R., and Sala M. Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system. Neuroscience 104 4 (2001) 923-926
7. Carr K.D., Kim G.Y., and Cabeza de Vaca S. Rewarding and locomotor-activating effects of direct dopamine receptor agonists are augmented by chronic food restriction in rats. Psychopharmacology (Berl) 154 4 (2001) 420-428
8. Cervo L., Rossi C., and Samanin R. Clonidine-induced place preference is mediated by alpha 2-adrenoceptors outside the locus coeruleus. Eur. J. Pharmacol. 238 2-3 (1993) 201-207
9. Clavier R.M., and Routtenberg A. Brain stem self-stimulation attenuated by lesions of medial forebrain bundle but not by lesions of locus coeruleus or the caudal ventral norepinephrine bundle. Brain Res. 101 2 (1976) 251-271
10. Crow T.J., Spear P.J., and Arbuthnott G.W. Intracranial self-stimulation with electrodes in the region of the locus coeruleus. Brain Res. 36 2 (1972) 275-287
11. Darracq L., Blanc G., Glowinski J., and Tassin J.P. Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of d-amphetamine. J. Neurosci. 18 7 (1998) 2729-2739
12. De Araujo J.E., Huston J.P., and Brandao M.L. Place aversion induced by microinjections of C-fragment of substance P into the dorsal periaqueductal gray of rats is mediated by tachykinin NK1 receptors. Peptides 22 9 (2001) 1447-1452
13. Delfs J.M., Zhu Y., Druhan J.P., and Aston-Jones G. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403 6768 (2000) 430-434
14. Di Chiara G., and Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U. S. A. 85 14 (1988) 5274-5278
15. Drago J., Padungchaichot P., Accili D., and Fuchs S. Dopamine receptors and dopamine transporter in brain function and addictive behaviors: insights from targeted mouse mutants. Dev. Neurosci. 20 2-3 (1998) 188-203
16. Drouin C., Darracq L., Trovero F., Blanc G., Glowinski J., Cotecchia S., and Tassin J.P. Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J. Neurosci. 22 7 (2002) 2873-2884
17. Duarte C., Biala G., Le Bihan C., Hamon M., and Thiebot M.H. Respective roles of dopamine D(2) and D(3) receptors in food-seeking behaviour in rats. Psychopharmacology (Berl) (2003)
18. Elmer G.I., Pieper J.O., Rubinstein M., Low M.J., Grandy D.K., and Wise R.A. Failure of intravenous morphine to serve as an effective instrumental reinforcer in dopamine D2 receptor knock-out mice. J. Neurosci. 22 10 (2002) RC224
19. Feenstra M.G. Dopamine and noradrenaline release in the prefrontal cortex in relation to unconditioned and conditioned stress and reward. Prog. Brain Res. 126 (2000) 133-163
20. Fibiger H.C., Phillips A.G., and Brown E.E. The neurobiology of cocaine-induced reinforcement. Ciba Found. Symp. 166 (1992) 96-111
21. Florin S.M., Kuczenski R., and Segal D.S. Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment. Brain Res. 654 1 (1994) 53-62
22. Gavioli E.C., Canteras N.S., and De Lima T.C. The role of lateral septal NK1 receptors in mediating anxiogenic effects induced by intracerebroventricular injection of substance P. Behav. Brain Res. 134 1-2 (2002) 411-415
23. Grenhoff J., Nisell M., Ferre S., Aston-Jones G., and Svensson T.H. Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J. Neural Transm. Gen. Sect. 93 1 (1993) 11-25
24. Guard S., Boyle S.J., Tang K.W., Watling K.J., McKnight A.T., and Woodruff G.N. The interaction of the NK1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences. Br. J. Pharmacol. 110 1 (1993) 385-391
25. Gygi S.P., Gibb J.W., Johnson M., and Hanson G.R. Blockade of tachykinin NK1 receptors by CP-96345 enhances dopamine release and the striatal dopamine effects of methamphetamine in rats. Eur. J. Pharmacol. 250 1 (1993) 177-180
26. Hall F.S., Li X.F., Sora I., Xu F., Caron M., Lesch K.P., Murphy D.L., and Uhl G.R. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions. Neuroscience 115 1 (2002) 153-161
27. Harris G.C., Hausken Z.E., and Williams J.T. Cocaine induced synchronous oscillations in central noradrenergic neurons in vitro. Neuroscience 50 2 (1992) 253-257
28. Hernandez L., and Hoebel B.G. Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis. Life Sci. 42 18 (1988) 1705-1712
29. Holman R.B. Biological effects of central nervous system stimulants. Addiction 89 11 (1994) 1435-1441
30. Horst W.D., and Preskorn S.H. Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. J. Affect. Disord. 51 3 (1998) 237-254
31. Hyman S.E., and Malenka R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2 10 (2001) 695-703
32. Jasmin L., Tien D., Weinshenker D., Palmiter R.D., Green P.G., Janni G., and Ohara P.T. The NK1 receptor mediates both the hyperalgesia and the resistance to morphine in mice lacking noradrenaline. Proc. Natl. Acad. Sci. U. S. A. 99 2 (2002) 1029-1034
33. Jasmin L., Boudah A., and Ohara P.T.O. Long-term effects of decreased noradrenergic CNS innervation on pain behavior and opioid antinociception. J. Comp. Neurol. 460 1 (2003) 38-55
34. Koob G.F. Neural mechanisms of drug reinforcement. Ann. N.Y. Acad. Sci. 654 (1992) 171-191
35. Kornetsky C., and Duvauchelle C. Dopamine, a common substrate for the rewarding effects of brain stimulation reward, cocaine, and morphine. NIDA Res. Monogr. 145 (1994) 19-39
36. Kuczenski R., and Segal D.S. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J. Neurochem. 68 5 (1997) 2032-2037
37. Kuhar M.J., Ritz M.C., and Boja J.W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14 7 (1991) 299-302
38. Lepore M., Vorel S.R., Lowinson J., and Gardner E.L. Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward. Life Sci. 56 23-24 (1995) 2073-2080
39. Li S.X., Perry K.W., and Wong D.T. Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats. Neuropharmacology 42 2 (2002) 181-190
40. Macey D.J., Smith H.R., Nader M.A., and Porrino L.J. Chronic cocaine self-administration upregulates the norepinephrine transporter and alters functional activity in the bed nucleus of the stria terminalis of the rhesus monkey. J. Neurosci. 23 1 (2003) 12-16
41. Maldonado R., Saiardi A., Valverde O., Samad T.A., Roques B.P., and Borrelli E. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388 6642 (1997) 586-589
42. Markou A., Kosten T.R., and Koob G.F. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 18 3 (1998) 135-174
43. Martinez-Pinero M.G., Milanes M.V., Alcaraz C., and Vargas M.L. Catecholaminergic mediation of morphine-induced activation of pituitary-adrenocortical axis in the rat: implication of alpha-and beta-adrenoceptors. Brain Res. 668 1-2 (1994) 122-128
44. Mason S.T., and Iversen S.D. Learning in the absence of forebrain noradrenaline. Nature 258 5534 (1975) 422-424
45. Matsuzawa S., Suzuki T., Misawa M., and Nagase H. Involvement of dopamine D(1) and D(2) receptors in the ethanol-associated place preference in rats exposed to conditioned fear stress. Brain Res. 835 2 (1999) 298-305
46. McAllister T.W. Apathy. Semin. Clin. Neuropsychiatry 5 4 (2000) 275-282
47. McAllister K.H., and Pratt J.A. GR205171 blocks apomorphine and amphetamine-induced conditioned taste aversions. Eur. J. Pharmacol. 353 2-3 (1998) 141-148
48. Mead A.N., Rocha B.A., Donovan D.M., and Katz J.L. Intravenous cocaine induced-activity and behavioural sensitization in norepinephrine-, but not dopamine-transporter knockout mice. Eur. J. Neurosci. 16 3 (2002) 514-520
49. Meyer J.H., Goulding V.S., Wilson A.A., Hussey D., Christensen B.K., and Houle S. Bupropion occupancy of the dopamine transporter is low during clinical treatment. Psychopharmacology (Berl) 163 1 (2002) 102-105
50. Mohammed A.K., Danysz W., Ogren S.O., and Archer T. Central noradrenaline depletion attenuates amphetamine-induced locomotor behavior. Neurosci. Lett. 64 (1986) 139-144
51. Morency M.A., and Beninger R.J. Dopaminergic substrates of cocaine-induced place conditioning. Brain Res. 399 1 (1986) 33-41
52. Murtra P., Sheasby A.M., Hunt S.P., and De Felipe C. Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature 405 6783 (2000) 180-183
53. Noda Y., Miyamoto Y., Mamiya T., Kamei H., Furukawa H., and Nabeshima T. Involvement of dopaminergic system in phencyclidine-induced place preference in mice pretreated with phencyclidine repeatedly. J. Pharmacol. Exp. Ther. 286 1 (1998) 44-51
54. Oleskevich S., and Williams J.T. Cocaine prolongs norepinephrine synaptic potentials in rat dorsal raphe. J. Neurophysiol. 73 2 (1995) 687-692
55. Ortmann R. The conditioned place preference paradigm in rats: effect of bupropion. Life Sci. 37 21 (1985) 2021-2027
56. Pandey S.C., Chartoff E.H., Carlezon Jr. W.A., Zou J., Zhang H., Kreibich A.S., Blendy J.A., and Crews F.T. CREB gene transcription factors: role in molecular mechanisms of alcohol and drug addiction. Alcohol Clin. Exp. Res. 29 2 (2005) 176-184
57. Placenza F.M., Fletcher P.J., Rotzinger S., and Vaccarino F.J. Infusion of the substance P analogue, DiMe-C7, into the ventral tegmental area induces reinstatement of cocaine-seeking behaviour in rats. Psychopharmacology (Berl) 177 1-2 (2004) 111-120
58. Puglisi-Allegra S., and Cabib S. Psychopharmacology of dopamine: the contribution of comparative studies in inbred strains of mice. Prog. Neurobiol. 51 6 (1997) 637-661
59. Reith M.E., Li M.Y., and Yan Q.S. Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers. Psychopharmacology (Berl) 134 3 (1997) 309-317
60. Rezayof A., Zarrindast M.R., Sahraei H., and Haeri-Rohani A.H. Involvement of dopamine D2 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat. Pharmacol. Biochem. Behav. 74 1 (2002) 187-197
61. Roberts D.C., Price M.T., and Fibiger H.C. The dorsal tegmental noradrenergic projection: an analysis of its role in maze learning. J. Comp. Physiol. Psychol. 90 4 (1976) 363-372
62. Rolls E.T., Kelly P.H., and Shaw S.G. Noradrenaline, dopamine, and brain-stimulation reward. Pharmacol. Biochem. Behav. 2 6 (1974) 735-740
63. Rothman R.B., Baumann M.H., Dersch C.M., Romero D.V., Rice K.C., Carroll F.I., and Partilla J.S. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39 1 (2001) 32-41
64. Rothman R.B., and Glowa J.R. A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development, Focus on GBR 12909. Mol. Neurobiol. 11 1-3 (1995) 1-19
65. Rupniak N.M. New insights into the antidepressant actions of substance P (NK1 receptor) antagonists. Can. J. Physiol. Pharmacol. 80 5 (2002) 489-494
66. Salmon P., and Stanford C. Peripheral noradrenaline depletion does not impair extinction of food-rewarded running in the rat. J. Auton. Nerv. Syst. 23 1 (1988) 79-81
67. Sarnyai Z., Shaham Y., and Heinrichs S.C. The role of corticotropin-releasing factor in drug addiction. Pharmacol. Rev. 53 2 (2001) 209-243
68. Sasaki-Adams D.M., and Kelley A.E. Serotonin-dopamine interactions in the control of conditioned reinforcement and motor behavior. Neuropsychopharmacology 25 3 (2001) 440-452
69. Schmidt A.W., McLean S., and Heym J. The substance P receptor antagonist CP-96,345 interacts with Ca2+ channels. Eur. J. Pharmacol. 219 3 (1992) 491-492
70. Sessions G.R., Kant G.J., and Koob G.F. Locus coeruleus lesions and learning in the rat. Physiol. Behav. 17 5 (1976) 853-859
71. Shelton R.C., and Tomarken A.J. Can recovery from depression be achieved?. Psychiatr. Serv. 52 11 (2001) 1469-1478
72. Sora I., Wichems C., Takahashi N., Li X.F., Zeng Z., Revay R., Lesch K.P., Murphy D.L., and Uhl G.R. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc. Natl. Acad. Sci. U. S. A. 95 13 (1998) 7699-7704
73. Spielewoy C., Gonon F., Roubert C., Fauchey V., Jaber M., Caron M.G., Roques B.P., Hamon M., Betancur C., Maldonado R., and Giros B. Increased rewarding properties of morphine in dopamine-transporter knockout mice. Eur. J. Neurosci. 12 5 (2000) 1827-1837
74. Spyraki C., Arbuthnott G.W., and Fibiger H.C. The effect of DSP-4 on some positively reinforced operant behaviors in the rat. Pharmacol. Biochem. Behav. 16 2 (1982) 197-202
75. Spyraki C., Fibiger H.C., and Phillips A.G. Cocaine-induced place preference conditioning: lack of effects of neuroleptics and 6-hydroxydopamine lesions. Brain Res. 253 1-2 (1982) 195-203
76. Stahl S.M., Pradko J.F., Haight B.R., Modell J.G., Rockett C.B., and Learned-Coughlin S. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim. Care Companion J. Clin. Psychiat. 6 4 (2004) 159-166
77. Subhan F., Deslandes P.N., Pache D.M., and Sewell R.D. Do antidepressants affect motivation in conditioned place preference?. Eur. J. Pharmacol. 408 3 (2000) 257-263
78. Svensson T.H. Brain noradrenaline and the mechanisms of action of antidepressant drugs. Acta Psychiatr. Scand. Suppl. 402 (2000) 18-27
79. Tanda G., Pontieri F.E., Frau R., and Di Chiara G. Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur. J. Neurosci. 9 10 (1997) 2077-2085
80. Thomas S.A., and Palmiter R.D. Disruption of the dopamine beta-hydroxylase gene in mice suggests roles for norepinephrine in motor function, learning, and memory. Behav. Neurosci. 111 3 (1997) 579-589
81. Thomas S.A., Marck B.T., Palmiter R.D., and Matsumoto A.M. Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine beta-hydroxylase. J. Neurochem. 70 6 (1998) 2468-2476
82. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56 6 (1998) 613-672
83. Uhl G.R., Hall F.S., and Sora I. Cocaine, reward, movement and monoamine transporters. Mol. Psychiatry 7 1 (2002) 21-26
84. Ventura R., Cabib S., Alcaro A., Orsini C., and Puglisi-Allegra S. Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release. J. Neurosci. 23 5 (2003) 1879-1885
85. Ventura R., Alcaro A., and Puglisi-Allegra S. Prefrontal cortical norepinephrine release is critical for morphine-induced reward, reinstatement and dopamine release in the nucleus accumbens. Cereb Cortex (2005)
86. Wang X., Cen X., and Lu L. Noradrenaline in the bed nucleus of the stria terminalis is critical for stress-induced reactivation of morphine-conditioned place preference in rats. Eur. J. Pharmacol. 432 2-3 (2001) 153-161
87. Wang G.J., Volkow N.D., and Fowler J.S. The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin. Ther. Targets 6 5 (2002) 601-609
88. Wise R.A., and Rompre P.P. Brain dopamine and reward. Annu. Rev. Psychol. 40 (1989) 191-225
89. Woolverton W.L. Evaluation of the role of norepinephrine in the reinforcing effects of psychomotor stimulants in rhesus monkeys. Pharmacol. Biochem. Behav. 26 4 (1987) 835-839
90. Xu F., Gainetdinov R.R., Wetsel W.C., Jones S.R., Bohn L.M., Miller G.W., Wang Y.M., and Caron M.G. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat. Neurosci. 3 5 (2000) 465-471
91. Zhu H., and Zhou W. Morphine induces synchronous oscillatory discharges in the rat locus coeruleus. J Neurosci. 21 21 (2001) RC179